Real-world Outcomes, Treatment Patterns and T790M Testing Rates in Non-small Cell Lung Cancer Patients Treated with First-line First- or Second-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors from the Slovenian Cohort of the REFLECT Study

BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR mutation-positive (EGFRm) non-small cell lung cancer (NSCLC). However, routine clinical practice is different between countries/institutions. PATIENTS AND METHODS: The REFLECT stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Turnsek, Nina, Devjak, Rok, Edelbaher, Natalija, Osrajnik, Ilonka, Unk, Mojca, Vidovic, Dusanka, Jeric, Tina, Janzic, Urska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400443/
https://www.ncbi.nlm.nih.gov/pubmed/35853681
http://dx.doi.org/10.2478/raon-2022-0025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400443/
https://www.ncbi.nlm.nih.gov/pubmed/35853681
http://dx.doi.org/10.2478/raon-2022-0025

Ejemplares similares